36355520|t|In Vitro, Molecular Docking and In Silico ADME/Tox Studies of Emodin and Chrysophanol against Human Colorectal and Cervical Carcinoma.
36355520|a|Anthraquinones (AQs) are present in foods, dietary supplements, pharmaceuticals, and traditional treatments and have a wide spectrum of pharmacological activities. In the search for anti-cancer drugs, AQ derivatives are an important class. In this study, anthraquinone aglycons chrysophanol (Chr), emodin (EM) and FDA-approved anticancer drug fluorouracil were analyzed by molecular docking studies against receptor molecules caspase-3, apoptosis regulator Bcl-2, TRAF2 and NCK-interacting protein kinase (TNIK) and cyclin-dependent protein kinase 2 (CDK2) as novel candidates for future anticancer therapeutic development. The ADMET SAR database was used to predict the toxicity profile and pharmacokinetics of the Chr and EM. Furthermore, in silico results were validated by the in vitro anticancer activity against HCT-116 and HeLa cell lines to determine the anticancer effect. According to the docking studies simulated by the docking program AutoDock Vina 4.0, Chr and EM had good binding energies against the target proteins. It has been observed that Chr and EM show stronger molecular interaction than that of the FDA-approved anticancer drug fluorouracil. In the in vitro results, Chr and EM demonstrated promising anticancer activity in HCT-116 and HeLa cells. These findings lay the groundwork for the potential use of Chr and EM in the treatment of human colorectal and cervical carcinomas.
36355520	62	68	Emodin	Chemical	MESH:D004642
36355520	73	85	Chrysophanol	Chemical	MESH:C027113
36355520	94	99	Human	Species	9606
36355520	100	133	Colorectal and Cervical Carcinoma	Disease	MESH:D015179
36355520	135	149	Anthraquinones	Chemical	MESH:D000880
36355520	151	154	AQs	Chemical	MESH:D000880
36355520	322	328	cancer	Disease	MESH:D009369
36355520	336	338	AQ	Chemical	MESH:D000880
36355520	390	412	anthraquinone aglycons	Chemical	-
36355520	413	425	chrysophanol	Chemical	MESH:C027113
36355520	427	430	Chr	Chemical	MESH:C027113
36355520	433	439	emodin	Chemical	MESH:D004642
36355520	441	443	EM	Chemical	MESH:D004642
36355520	478	490	fluorouracil	Chemical	MESH:D005472
36355520	561	570	caspase-3	Gene	836
36355520	592	597	Bcl-2	Gene	596
36355520	599	604	TRAF2	Gene	7186
36355520	641	645	TNIK	Gene	23043
36355520	651	684	cyclin-dependent protein kinase 2	Gene	1017
36355520	686	690	CDK2	Gene	1017
36355520	806	814	toxicity	Disease	MESH:D064420
36355520	851	854	Chr	Chemical	MESH:C027113
36355520	859	861	EM	Chemical	MESH:D004642
36355520	953	960	HCT-116	CellLine	CVCL:0291
36355520	965	969	HeLa	CellLine	CVCL:0030
36355520	1102	1105	Chr	Chemical	MESH:C027113
36355520	1110	1112	EM	Chemical	MESH:D004642
36355520	1194	1197	Chr	Chemical	MESH:C027113
36355520	1202	1204	EM	Chemical	MESH:D004642
36355520	1287	1299	fluorouracil	Chemical	MESH:D005472
36355520	1326	1329	Chr	Chemical	MESH:C027113
36355520	1334	1336	EM	Chemical	MESH:D004642
36355520	1383	1390	HCT-116	CellLine	CVCL:0291
36355520	1395	1399	HeLa	CellLine	CVCL:0030
36355520	1466	1469	Chr	Chemical	MESH:C027113
36355520	1474	1476	EM	Chemical	MESH:D004642
36355520	1497	1502	human	Species	9606
36355520	1503	1537	colorectal and cervical carcinomas	Disease	MESH:D015179
36355520	Comparison	MESH:D004642	MESH:D005472
36355520	Comparison	MESH:C027113	MESH:D004642
36355520	Association	MESH:D005472	596
36355520	Negative_Correlation	MESH:D000880	MESH:D009369
36355520	Association	MESH:D005472	1017
36355520	Negative_Correlation	MESH:D004642	MESH:D015179
36355520	Negative_Correlation	MESH:C027113	MESH:D015179
36355520	Association	MESH:D005472	7186
36355520	Comparison	MESH:C027113	MESH:D005472

